Trials / Completed
CompletedNCT05928637
A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150
An Open-label, Randomized, Multiple-dose, Three-way Crossover Study to Compare the Pharmacokinetic Characteristics and Safety Among D745, D759, and D150 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
A clinical trial to compare the pharmacokinetic characteristics and safety among D745, D759, and D150 in healthy subjects
Detailed description
An open-label, randomized, multiple-dose, three-way crossover study to compare the pharmacokinetic characteristics and safety among D745, D759, and D150 in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | D745, D759, D150 | QD, PO for 5 days |
Timeline
- Start date
- 2023-07-10
- Primary completion
- 2023-08-29
- Completion
- 2023-09-05
- First posted
- 2023-07-03
- Last updated
- 2024-03-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05928637. Inclusion in this directory is not an endorsement.